Abstract
Purpose
Development of an efficient and reliable PGD protocol for nonsyndromic deafness, by polar body (PB) and blastomere PGD.
Methods
The GJB2/GJB6 mutations along with 12 polymorphic markers were used in PGD analysis of blastomeres or polar bodies in 14 couples for 35 cycles. Marker informativity, diagnosis rates, Allele Drop Out (ADO) rates and PB1 heterozygosity rates were assessed.
Results
Six cycles were performed by PB biopsy, 27 by blastomere and two combined cycles, resulting in delivery of three unaffected children and five ongoing pregnancies. Diagnosis rates for PB and blastomeres were similar. Only 17% PB1s were heterozygote. ADO rates of 19% were observed in both groups.
Conclusions
We have developed a single cell multiplex PGD protocol for nonsyndromic deafness with a high efficiency of diagnosis. Most PB1 are homozygous, and similar ADO rates were observed; therefore, blastomere biopsy appears to be the method of choice for this autosomal recessive disease.
Similar content being viewed by others
References
Postelmans JT, Cleffken B, Stokroos RJ. Post-operative complications of cochlear implantation in adults and children: five years’ experience in Maastricht. J Laryngol Otol. 2007;121:318–23.
Petersen MB, Willems PJ. Non-syndromic, autosomal-recessive deafness. Clin Genet. 2006;69:371–92.
Marazita ML, Ploughman LM, Rawlings B, Remington E, Arnos KS, Nance WE. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet. 1993;46:486–91.
Rabionet R, Gasparini P, Estivill X. Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins. Hum Mutat. 2000;16:190–202.
Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ, Allen-Powell DR, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet. 1997;6:2173–7.
Morell RJ, Kim HJ, Hood LJ, Goforth L, Friderici K, Fisher R, et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med. 1998;339:1500–5.
Middleton A, Hewison J, Mueller RF. Attitudes of deaf adults toward genetic testing for hereditary deafness. Am J Hum Genet. 1998;63:1175–80.
Middleton A, Hewison J, Mueller R. Prenatal diagnosis for inherited deafness—what is the potential demand? J Genet Couns. 2001;10:121–31.
Bick DP, Lau EC. Preimplantation genetic diagnosis. Pediatr Clin North Am. 2006;53:559–77.
Verlinsky Y, Cohen J, Munne S, Gianaroli L, Simpson JL, Ferraretti AP, et al. Over a decade of experience with preimplantation genetic diagnosis. Fertil Steril. 2004;82:302–3.
Kakourou G, Dhanjal S, Daphnis D, Doshi A, Nuttall S, Gotts S, et al. Preimplantation genetic diagnosis for myotonic dystrophy type 1: detection of crossover between the gene and the linked marker APOC2. Prenat Diagn. 2007;27:111–6.
Tomi D, Schultze-Mosgau A, Eckhold J, Schopper B, Al-Hasani S, Steglich C, et al. First pregnancy and life after preimplantation genetic diagnosis by polar body analysis for mucopolysaccharidosis type I. Reprod Biomed Online. 2006;12:215–20.
Verlinsky Y, Rechitsky S, Verlinsky O, Kenigsberg D, Moshella J, Ivakhnenko V, et al. Polar body-based preimplantation diagnosis for X-linked disorders. Reprod Biomed Online. 2002;4:38–42.
Verlinsky I, Kuliev A. Micromanipulation and biopsy of polar bodies and blastomeres. In: Verlinsky IKA, editor. Atlas of preimplantation genetic diagnosis. 2nd ed. Abrington, Oxon: Taylor and Francis; 2005. p. 15–22.
Thornhill AR, McGrath JA, Eady RA, Braude PR, Handyside AH. A comparison of different lysis buffers to assess allele dropout from single cells for preimplantation genetic diagnosis. Prenat Diagn. 2001;21:490–7.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, et al. The UCSC genome browser database. Nucleic Acids Res. 2003;31:51–4.
Thornhill AR, deDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, et al. ESHRE PGD consortium ‘Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)’. Hum Reprod. 2005;20:35–48.
Estivill X, Fortina P, Surrey S, Rabionet R, Melchionda S, D’Agruma L, et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet. 1998;351:394–8.
Stern SJ, Arnos KS, Murrelle L, Welch KO, Nance WE, Pandya A. Attitudes of deaf and hard of hearing subjects towards genetic testing and prenatal diagnosis of hearing loss. J Med Genet. 2002;39:449–53.
Pickering SJ, McConnell JM, Johnson MH, Braude PR. Use of a polymorphic dinucleotide repeat sequence to detect non-blastomeric contamination of the polymerase chain reaction in biopsy samples for preimplantation diagnosis. Hum Reprod. 1994;9:1539–45.
Rechitsky S, Freidine M, Verlinsky Y, Strom CM. Allele dropout in sequential PCR and FISH analysis of single cells (cell recycling). J Assist Reprod Genet. 1996;13:115–24.
Rechitsky S, Strom C, Verlinsky O, Amet T, Ivakhnenko V, Kukharenko V, et al. Allele dropout in polar bodies and blastomeres. J Assist Reprod Genet. 1998;15:253–7.
Altarescu GE-GT, Brooks B, Margalioth EJ, Lahad A, Levy-Lahad E, Renbaum P, editor. Polar body versus blastomere: PB or not PB? The American Society of Human Genetics 56th Anual Meeting; 2006; New Orleans, Louisiana.
Harper JC, de Die-Smulders C, Goossens V, Harton G, Moutou C, Repping S, et al. ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Hum Reprod. 2008;23:741–55.
Acknowledgments
We would like to thank Rabbi David and Anita Fuld for their generous and ongoing support.
Disclosure of interests
Nothing to disclose
Contribution to authorship
Gheona Altarescu and Paul Renbaum were the principal investigators and responsible with the design of the methods, genetic counseling and analysis of all cases.
Talia Eldar Geva and Ehud J. Margalioth were the IVF physicians that performed all the IVF cycles of these patients.
Baruch Brooks, Edith Zylber-Haran PhD and Irit Varshaver were the embryologist that performed all the polar body and blastomere biopsies
Ephrat Levy-Lahad was involved in the analysis of the cases.
Ethics approval
The PGD is performed in our medical center as routine medical procedure and is not experimental therefore IRB was not required.
Funding
The funding was partly provided by the HMOs and partly by a private fund of Fuld family (see acknowledgments).
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule
A PGD protocol is presented for nonsyndromic deafness. Blastomere analysis was found to be preferable to polar body analysis for the GJB2 and GJB6 genes.
Rights and permissions
About this article
Cite this article
Altarescu, G., Eldar-Geva, T., Brooks, B. et al. Preimplantation genetic diagnosis (PGD) for nonsyndromic deafness by polar body and blastomere biopsy. J Assist Reprod Genet 26, 391–397 (2009). https://doi.org/10.1007/s10815-009-9335-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-009-9335-5